McGuire Investment Group »

Crispr Therapeutics shares owned by McGuire Investment Group

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by McGuire Investment Group from 13F filings

Historical chart of McGuire Investment Group investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by McGuire Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by McGuire Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.7M 59k 62.60
2023-09-30 $2.7M 59k 45.39
2023-06-30 $3.2M 57k 56.14
2023-03-31 $2.4M 53k 45.23
2022-12-31 $1.5M 36k 40.65
2022-09-30 $303k 4.6k 65.32
2022-06-30 $273k 4.5k 60.82
2022-03-31 $232k 3.7k 62.72
2021-09-30 $229k 2.0k 111.76
2021-06-30 $332k 2.0k 162.03
2021-03-31 $267k 2.2k 121.64
2020-12-31 $265k 1.7k 153.09
2020-09-30 $233k 2.8k 83.78
2020-06-30 $239k 3.3k 73.52